# Ocular Therapeutix, Inc: filings

OCUL · Nasdaq · CIK 1393434 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ocul.md) · [Financials](/companies/ocul/financials.md) · [Filings](/companies/ocul/filings.md) · [Insiders](/companies/ocul/insiders.md)

## Reports and events: 230 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 307, 8-K 157, 144 82, 3 44, 10-Q 37, SC 13G/A 37, SC 13G 22, S-8 21, 424B5 15, 10-K 12, DEF 14A 12, DEFA14A 11, CORRESP 9, SCHEDULE 13G/A 9, S-8 POS 8, EFFECT 7, UPLOAD 7, CT ORDER 5, D 5, SC 13D/A 5, ARS 4, S-3 4, PRE 14A 3, S-1/A 3, S-3ASR 3, SCHEDULE 13G 3, D/A 2, S-1 2, SC 13D 2, SEC STAFF LETTER 2, 424B1 1, 424B2 1, 424B3 1, 424B4 1, 8-A12B 1, CERTNAS 1, DEL AM 1, DRS 1, DRS/A 1, FWP 1, POS AM 1, POSASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 20:15 ET | [8-K](/filings/0001104659-26-116617.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-116617 |
| 2026-08-03 | 11:16 ET | [10-Q](/filings/0001104659-26-089450.md) | Quarterly report, period 2026-06-30 | 0001104659-26-089450 |
| 2026-08-03 | 11:07 ET | [8-K](/filings/0001104659-26-089443.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-089443 |
| 2026-06-12 | 20:23 ET | [8-K](/filings/0001104659-26-073496.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073496 |
| 2026-05-05 | 11:28 ET | [10-Q](/filings/0001104659-26-055256.md) | Quarterly report, period 2026-03-31 | 0001104659-26-055256 |
| 2026-05-05 | 11:06 ET | [8-K](/filings/0001104659-26-055241.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055241 |
| 2026-04-30 | 21:17 ET | [DEF 14A](/filings/0001104659-26-053176.md) | Proxy statement, period 2026-06-11 | 0001104659-26-053176 |
| 2026-02-27 | 21:02 ET | [8-K](/filings/0001104659-26-021541.md) | 7.01 Regulation FD disclosure | 0001104659-26-021541 |
| 2026-02-05 | 12:58 ET | [10-K](/filings/0001104659-26-010664.md) | Annual report, period 2025-12-31 | 0001104659-26-010664 |
| 2026-02-05 | 12:13 ET | [8-K](/filings/0001104659-26-010633.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-010633 |
| 2026-01-23 | 12:00 ET | [8-K](/filings/0001104659-26-006015.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-006015 |
| 2025-12-18 | 21:30 ET | [8-K](/filings/0001104659-25-122564.md) | 8.01 Other events | 0001104659-25-122564 |
| 2025-12-05 | 22:17 ET | [8-K](/filings/0001104659-25-118940.md) | 8.01 Other events | 0001104659-25-118940 |
| 2025-11-04 | 12:25 ET | [10-Q](/filings/0001104659-25-105919.md) | Quarterly report, period 2025-09-30 | 0001104659-25-105919 |
| 2025-11-04 | 12:19 ET | [8-K](/filings/0001104659-25-105914.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105914 |
| 2025-09-30 | 12:21 ET | [8-K](/filings/0001104659-25-094758.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094758 |
| 2025-09-30 | 10:32 ET | [8-K](/filings/0001104659-25-094724.md) | 8.01 Other events | 0001104659-25-094724 |
| 2025-08-05 | 11:11 ET | [10-Q](/filings/0001558370-25-010177.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010177 |
| 2025-08-05 | 11:06 ET | [8-K](/filings/0001104659-25-073909.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-073909 |
| 2025-06-11 | 20:02 ET | [8-K](/filings/0001104659-25-058525.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-058525 |
| 2025-05-05 | 11:47 ET | [10-Q](/filings/0001558370-25-006225.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006225 |
| 2025-05-05 | 11:06 ET | [8-K](/filings/0001104659-25-044349.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-044349 |
| 2025-04-29 | 21:00 ET | [DEF 14A](/filings/0001558370-25-005868.md) | Proxy statement, period 2025-06-11 | 0001558370-25-005868 |
| 2025-03-03 | 12:19 ET | [10-K](/filings/0001558370-25-002000.md) | Annual report, period 2024-12-31 | 0001558370-25-002000 |
| 2025-03-03 | 12:07 ET | [8-K](/filings/0001104659-25-019462.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-019462 |
| 2025-02-14 | 12:32 ET | [8-K](/filings/0001104659-25-013473.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-013473 |
| 2024-11-14 | 12:15 ET | [10-Q](/filings/0001558370-24-015613.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015613 |
| 2024-11-14 | 12:10 ET | [8-K](/filings/0001104659-24-118284.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118284 |
| 2024-10-09 | 20:20 ET | [8-K](/filings/0001104659-24-107348.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-107348 |
| 2024-09-03 | 12:01 ET | [8-K](/filings/0001104659-24-096021.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-096021 |
| 2024-08-07 | 11:23 ET | [10-Q](/filings/0001558370-24-011202.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011202 |
| 2024-08-07 | 11:13 ET | [8-K](/filings/0001104659-24-086535.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086535 |
| 2024-06-14 | 13:03 ET | [8-K](/filings/0001104659-24-071530.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071530 |
| 2024-06-03 | 13:15 ET | [8-K](/filings/0001104659-24-067544.md) | 2.05 Exit or disposal costs | 0001104659-24-067544 |
| 2024-05-07 | 20:20 ET | [10-Q](/filings/0001558370-24-007065.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007065 |
| 2024-05-07 | 20:10 ET | [8-K](/filings/0001104659-24-058003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058003 |
| 2024-04-29 | 20:10 ET | [DEF 14A](/filings/0001558370-24-006110.md) | Proxy statement, period 2024-06-12 | 0001558370-24-006110 |
| 2024-04-18 | 20:12 ET | [8-K](/filings/0001104659-24-048850.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-048850 |
| 2024-03-29 | 21:11 ET | [8-K](/filings/0001104659-24-041224.md) | 8.01 Other events | 0001104659-24-041224 |
| 2024-03-11 | 20:12 ET | [10-K](/filings/0001558370-24-002902.md) | Annual report, period 2023-12-31 | 0001558370-24-002902 |
| 2024-03-11 | 20:10 ET | [8-K](/filings/0001104659-24-032974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-032974 |
| 2024-02-27 | 21:30 ET | [SC 13D/A](/filings/0001140361-24-009774.md) | Ownership report, active investor, amended | 0001140361-24-009774 |
| 2024-02-22 | 12:34 ET | [8-K](/filings/0001104659-24-026324.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-026324 |
| 2024-01-25 | 13:04 ET | [8-K](/filings/0001104659-24-006490.md) | 8.01 Other events | 0001104659-24-006490 |
| 2023-12-18 | 21:52 ET | [SC 13D/A](/filings/0001140361-23-058175.md) | Ownership report, active investor, amended | 0001140361-23-058175 |
| 2023-12-14 | 13:46 ET | [8-K](/filings/0001104659-23-125888.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-125888 |
| 2023-11-07 | 21:06 ET | [10-Q](/filings/0001558370-23-017989.md) | Quarterly report, period 2023-09-30 | 0001558370-23-017989 |
| 2023-11-07 | 21:04 ET | [8-K](/filings/0001104659-23-115223.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115223 |
| 2023-10-04 | 13:02 ET | [8-K](/filings/0001104659-23-106651.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-106651 |
| 2023-10-03 | 20:15 ET | [8-K](/filings/0001104659-23-106399.md) | 8.01 Other events | 0001104659-23-106399 |

Page 1 of 5. [Older](/companies/ocul/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.